Glucagon-like peptide 1-based therapies and risk of pancreatitis: a self-controlled case series analysis

2013 ◽  
Vol 23 (3) ◽  
pp. 234-239 ◽  
Author(s):  
Xiaochun Li ◽  
Zuoyi Zhang ◽  
Jon Duke
Keyword(s):  
Case Series ◽  
Series Analysis ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

scholarly journals Effects of glucagon‐like peptide‐1 analogue treatment in genetic obesity: A case series

2021 ◽  
Author(s):  
Mila S. Welling ◽  
Cornelis J. Groot ◽  
Lotte Kleinendorst ◽  
Bibian Voorn ◽  
Jan Steven Burgerhart ◽  
...  
Keyword(s):  
Case Series ◽  
Genetic Obesity ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

scholarly journals Effects of Combination of SGLT-2 Inhibitor and GLP-1 Receptor Agonist on Renal Outcome in T2D with GFR below 30 and Macroalbuminuria : A Case Series

2020 ◽  
Author(s):  
Nitesh Kuhadiya ◽  
Israa Mahmood
Keyword(s):  
Combination Therapy ◽  
Receptor Agonist ◽  
Case Series ◽  
Renal Outcome ◽  
Renal Protection ◽  
Estimated Gfr ◽  
Risk Patients ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

We hypothesized that the combination therapy of SGLT-2(Sodium-glucose co-transporter-2)inhibitor and Glucagon-like peptide-1 receptor agonist(GLP-1RA) provide renal protection in adults with T2D with estimated GFR (eGFR) below 30ml/minute/1.73 m2. We hereby describe four consecutively treated high renal risk patients with T2D with eGFR between 21 to 30ml/minute/1.73m2.

Effects of glucagon-like peptide-1 (GLP-1) on gastric accommodation, emptying and satiety in humans

2001 ◽  
Vol 120 (5) ◽  
pp. A74-A74
Author(s):  
S AROS ◽  
D KIM ◽  
D BURTON ◽  
G THOMFORDE ◽  
A VELLA ◽  
...  
Keyword(s):  
Gastric Accommodation ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Eine häufige genetische Variation in WFS1 bedingt eine gestörte Glucagon-like Peptide-1-induzierte Insulinsekretion

2009 ◽  
Vol 4 (S 01) ◽  
Author(s):  
K Müssig ◽  
SA Schäfer ◽  
H Staiger ◽  
F Machicao ◽  
N Stefan ◽  
...  
Keyword(s):  
Genetische Variation ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Dulaglutide, a glucagon-like peptide-1 receptor agonist: in the search for survival molecule

2020 ◽  
Vol 9 (2) ◽  
pp. 49-58
Author(s):  
A.S. Ametov ◽  
◽  
A.O. Nevolnikova ◽  
E.A. Tertychnaya ◽  
O.A. Mishra ◽  
...  
Keyword(s):  
Receptor Agonist ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document